NCT02455557 2026-03-30SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed GlioblastomaRoswell Park Cancer InstitutePhase 2 Active not recruiting66 enrolled 11 charts
NCT00020267 2024-03-04Vaccine Therapy in Treating Patients With Metastatic CancerNational Cancer Institute (NCI)Phase 1 Completed